[Diagnosis and treatment strategies of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviral drugs].

The occult progression of chronic hepatitis C (CHC) is one of the main causes of liver cirrhosis and hepatocellular carcinoma (HCC). Recently, antiviral treatment of CHC has achieved great progress with the advent of direct-acting antiviral drugs (DAA), especially for special populations including advanced liver disease and HCC. However, DAA and HCC-related issues have also become one of the important concerns of current CHC treatment. This article summarizes the recent research progresses made in the diagnosis and treatment of HCV-related HCC.慢性丙型肝炎（CHC）隐匿进展是导致肝硬化和肝细胞癌（HCC）的主要原因之一。近年来，随着直接抗病毒药物（DAAs）的问世，CHC尤其是特殊人群包括进展期肝病和HCC的抗病毒治疗取得了巨大进展。DAAs和HCC的相关问题也成为目前CHC治疗的重要关注点之一。现就近年来丙型肝炎相关HCC诊治的最新研究进展进行综述。.